✦ LIBER ✦

Sirolimus Compared To Methotrexate Based Immunosuppression For Graft-versus-Host Disease (GvHD) Prophylaxis In Allogeneic Stem Cell Transplantation: A Single Institution Experience

✍ Scribed by P.J. Kiel; L.L. Rosenbeck; I. Kalsekar; J. Baute; S. Abdelqader; C.K. Sullivan; J. Schwartz; S. Srivastava; R. Abonour; M.J. Robertson; R.P. Nelson; C.A. Fausel; S.S. Farag

Book ID: 116281683
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 55 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.488

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus and tacrolimus as graft-versus

Sirolimus and tacrolimus as graft-versus-host disease prophylaxis in allogeneic stem cell transplantation: The Dana Farber Cancer Institute experience

✍ C. Cutler; S. Li; H.T. Kim; E. Alyea; V. Ho; S.J. Lee; R. Soiffer; J. Antin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB

160: Fasciitis as a manifestation of chr

160: Fasciitis as a manifestation of chronic graft versus host disease following allogeneic hematopoietic stem cell transplantation in children and adolescents: A single institution experience

✍ C.N. Duncan; K.L. Myers; L.E. Lehmann 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Cell dose and graft versus host disease

Cell dose and graft versus host disease (GVHD) affect survival in allogeneic peripheral blood stem cell transplantation (alloPBSCT) following non-myeloablative (NM) conditioning: A single center experience

✍ J.L. Johnson; M. Vusirikala; W. Chinratanalab; S. Brandt; Y. Shyr; B. Shakhtour; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Posaconazole (POS) vs fluconazole (FLU)

Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): A multicenter trial

✍ S. Durrant; D. Vesole; A. Langston; J.H. Lipton; H. Patino; L. Pedicone; A.J. Ul 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

A Phase I/II study of the safety and eff

A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)

✍ Michael A. Pulsipher; Donna A. Wall; Michael Grimley; Rakesh K. Goyal; Kenneth M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Relapse to prior autograft and chronic g

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma

✍ Nicolaus Kröger; Jose A. Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 289 KB